« Lilly's R&D Outsourcing |
| Extortion, Retractions, And More »
January 6, 2010
Five Technologies For the Scrap Heap?
Xconomy has a piece on biotechnologies that look to be headed for obsolescence. I think the list is mostly correct - it includes the raw proteomic approach to understanding disease states and a lot of the biomarker work being done currently. I won't spoil the rest of the list; take a look and see what you think. Note: RNA interference is not on it, in case you're wondering. Nor are stem cells.
+ TrackBacks (0) | Category: Biological News
POST A COMMENT
- RELATED ENTRIES
- Scripps Update
- What If Drug Patents Were Written Like Software Patents?
- Stem Cells: The Center of "Right to Try"
- Speaking of Polyphenols. . .
- Dark Biology And Small Molecules
- How Polyphenols Work, Perhaps?
- More On Automated Medicinal Chemistry
- Scripps Merging With USC?